Clinical Trial Update: Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating chlorambucil in metastatic pancreatic ductal adenocarcinoma patients with germline DNA repair mutations (SALE trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Chlorambucil (chlorambucil)

Snippet

Sponsor: Michele Reni | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: UNKNOWN